ArticleWorld journal of urology2024

PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions.

Jeremy Kwe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.